BingMei Hao brings close to 30 years of extensive finance and accounting experience to her role as Chief Financial Officer, with a career that spans both the public (Ernst & Young LLP) and private sectors. Her expertise has been honed over 18 years in the pharmaceutical industry, with pivotal roles at ThermoFisher Scientific, Biogen and Ferring Pharmaceuticals.

Prior to her current position, Bing served as the Chief Financial Officer of Medair where she oversaw financial strategies and operations and served as Finance Director for Biogen’s International Distributor Group. At Ferring Pharmaceuticals, she made her mark as the Global Controller for Global Manufacturing, and later as Regional Chief Financial Officer for the Asia Pacific region.